Inventor · disambiguated record
Michael Gallo
Also filed as: GALLO MICHAEL · GALLO MICHAEL L · GALLO MICHAEL LAJOS
22 granted patents·15 pending applications·1,690 citations·filing 1997–2023
96Inventor score
Top patents by PatentIndex Score
37 records- 0198US6235883B1Human monoclonal antibodies to epidermal growth factor receptorABGENIX INC·Filed 1997·Granted May 22, 2001·831 cites·16 claims
- 0297US7807798B2Human monoclonal antibodies to epidermal growth factor receptorAMGEN FREMONT INC·Filed 2005·Granted Oct 5, 2010·37 cites·11 claims
- 0397US7037498B2Antibodies to insulin-like growth factor I receptorPFIZER·Filed 2002·Granted May 2, 2006·252 cites·130 claims
- 0497US5985615ADirected switch-mediated DNA recombinationABGENIX INC·Filed 1997·Granted Nov 16, 1999·346 cites·31 claims
- 0594US8568992B2Antibody categorization based on binding characteristicsWALKER WYNN L·Filed 2012·Granted Oct 29, 2013·53 cites·57 claims
- 0694US7700742B2Antibodies to insulin-like growth factor I receptorAMGEN FREMONT·Filed 2005·Granted Apr 20, 2010·34 cites·18 claims
- 0793US7815907B2Antibodies to insulin-like growth factor I receptorAMGEN FREMONT INC·Filed 2005·Granted Oct 19, 2010·21 cites·97 claims
- 0893US7378091B2Antibodies against carbonic anhydrase IX (CA IX) tumor antigenAMGEN FREMONT INC·Filed 2002·Granted May 27, 2008·44 cites·25 claims
- 0991US8012714B2Sequence diversity generation in immunoglobulinsINNOVATIVE TARGETING SOLUTIONS INC·Filed 2009·Granted Sep 6, 2011·17 cites·44 claims
- 1090US9315577B2Anti-hepcidin antibodies and methods of useFOLTZ IAN·Filed 2009·Granted Apr 19, 2016·24 cites·2 claims
- 1189US7982024B2Antibodies to insulin-like growth factor I receptorAMGEN FREMONT INC·Filed 2010·Granted Jul 19, 2011·11 cites·24 claims
- 1286US8227580B2Human monoclonal antibodies to epidermal growth factor receptorJAKOBOVITS AYA·Filed 2010·Granted Jul 24, 2012·3 cites·1 claims
- 1386US8206936B2Antibody categorization based on binding characteristicsWALKER WYNN L·Filed 2010·Granted Jun 26, 2012·3 cites·52 claims
- 1483US8617845B2Sequence diversity generation in immunoglobulinsGALLO MICHAEL·Filed 2011·Granted Dec 31, 2013·4 cites·22 claims
- 1581US7771951B2Antibody categorization based on binding characteristicsAMGEN FREMONT INC·Filed 2002·Granted Aug 10, 2010·5 cites·52 claims
- 1677US10233453B2Generating targeted sequence diversity in fusion proteinsINNOVATIVE TARGETING SOLUTIONS INC·Filed 2017·Granted Mar 19, 2019·1 cites·18 claims
- 1774US2014178905A1Antibody categorization based on binding characteristicsAMGEN INC·Filed 2013·Application pending·0 cites
- 1873US9718871B2Generating targeted sequence diversity in proteinsINNOVATIVE TARGETING SOLUTIONS INC·Filed 2013·Granted Aug 1, 2017·2 cites·16 claims
- 1967US10563206B2Generating targeted sequence diversity in fusion proteinsINNOVATIVE TARGETING SOLUTIONS INC·Filed 2019·Granted Feb 18, 2020·0 cites·16 claims
- 2067US2005100546A1Human monoclonal antibodies to epidermal growth factor receptorABGENIX INC·Filed 2004·Application pending·0 cites
- 2165US9234041B2Antibodies to insulin-like growth factor I receptorAMGEN FREMONT INC·Filed 2013·Granted Jan 12, 2016·0 cites·20 claims
- 2264US2025110134A1Stabilized Single Immunoglobulin Variable DomainsTENTARIX BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2360US9914929B2Generating targeted sequence diversity in fusion proteinsINNOVATIVE TARGETING SOLUTIONS INC·Filed 2013·Granted Mar 13, 2018·0 cites·17 claims
- 2459US2003190751A1Directed switch-mediated DNA recombinationFiled 2002·Application pending·0 cites
- 2558US2016096894A1Antibodies to insulin-like growth factor i receptorPFIZER·Filed 2015·Application pending·0 cites
- 2654US8642037B2Antibodies to insulin-like growth factor I receptorCOHEN BRUCE D·Filed 2011·Granted Feb 4, 2014·0 cites·16 claims
- 2750US2005142137A1Antibodies against secretoryleukocyte protease inhibitorCURAGEN CORP·Filed 2004·Application pending·0 cites
- 2846US2017334970A1Generating Targeted Sequence Diversity in ProteinsINNOVATIVE TARGETING SOLUTIONS INC·Filed 2017·Application pending·0 cites
- 2944US2013236931A1Sequence diversity generation in immunoglobulins and other proteinsGALLO MICHAEL·Filed 2013·Application pending·0 cites
- 3044US2016297883A1G-protein coupled receptor agonists and methodsINNOVATIVE TARGETING SOLUTIONS INC·Filed 2014·Application pending·0 cites
- 3143US2005107596A1Anti-alpha3(IV)nc1 monoclonal antibodies and animal model for human anti-glomerular basement membrane autoantibody diseaseFiled 2002·Application pending·0 cites
- 3242US2019359937A1Chimeric receptors, biosensor host cells and methods/uses thereofINNOVATIVE TARGETING SOLUTIONS INC·Filed 2017·Application pending·0 cites
- 3341US6395515B1Directed switch-mediated DNA recombinationABGENIX INC·Filed 1999·Granted May 28, 2002·2 cites·3 claims
- 3441US2003175760A1Discovery of therapeutic productsFiled 2002·Application pending·0 cites
- 3534US2002173629A1Human monoclonal antibodies to epidermal growth factor receptorFiled 1998·Application pending·0 cites
- 3634US2019255186A1Single variable domain t-cell receptorsINNOVATIVE TARGETING SOLUTIONS INC·Filed 2016·Application pending·0 cites
- 3728US2002142374A1Generation of modified molecules with increased serum half-livesFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Gallo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →